VBS 2021: The Force Awakens Episode 1

Sunday, August 1, 2021, 12:00 AM - Sunday, July 31, 2022, 11:59 PM

The primary goal of the Virtual Series is to bring retina surgeons together who are committed to sharing innovative strategies to foster best practices for the management of retinal pathologies.

Topics will include, but are not limited to, debates on secondary IOL approaches, macular degeneration treatments on the horizon, surgical approaches to trauma, diversity, equity and inclusion, surgical management of uveitis patients, debates on vitrectomy platforms, OCT interpretation, debates on approaches to macular hole repair, job contracts, and approaches to surgical complications.

VBS 2021: The Force Awakens, Episode 1  (Recording from April 14, 2021) 

Release Date: August 1, 2021  |  Expiration Date: July 31, 2022  |   Estimated Time to Complete: 90 minutes

Moderated by Aleksandra Rachitskaya, MD; Priya Sharma Vakharia, MD; Basil Williams, Jr., MD

• Introduction - Charles Wykoff, MD, PhD
• Do or do not do, there is no try: IOL Acrobatics Debates      
  • Scleral Haptic Fixation - Maria Berrocal, MD      
  • Gore-tex Sutered Lenses - Joseph Coney, MD      
  • Iris Sutured - Ninel Gregori, MD      
  • ACIOL - Katherine Talcott, MD      
  • Discussion + Voting
• This is not the medical retina you were looking for: Surgical Approaches in Medical Retina and Discussion - Lejla Vajzovic, MD
• Impressive, most impressive: Lightning Surgical Rounds - Matthew Cunningham, MD; Kristen Harris-Nwanyanwu, MD, MBA; Marianeli Rodriguez, MD
• I find your lack of faith disturbing: Handling Trauma as a Retinal Surgeon and Discussion - Yewlin Chee, MD
• Bringing Balance to the Force: Diversity, Equity, & Inclusion in Retina Panel - Moderated by Basil Williams, Jr., MD; Panelists - Jessica Randolph, MD; Reginald Sanders, MD
• That's not how the Force works! Uveitis Surgery Pearls and Discussion - Lisa Faia, MD
• Closing Remarks - Geeta Lalwani, MD

1. Evaluate and treat patients with aphakia or dislocated lenses: including demonstration of different secondary lens approaches; explaining advantages and disadvantages of these various techniques; and comparing surgical outcomes between the secondary lens approaches.
2. Describe emerging therapeutics for the treatment of neovascular age related macular degeneration that will potentially be available in the near future, including gene therapy and the port delivery system.
3. Managing cases of intraocular trauma as a vitreoretinal surgeon, including demonstration of vitreoretinal surgical techniques in trauma and the application of advanced vitrectomy techniques.
4. Discuss challenging vitreoretinal surgical cases and surgical techniques for successfully managing these cases.
5. Discuss the status of diversity in ophthalmology, specifically within retina as a subspecialty, and formulate successful approaches to improving diversity, equity and inclusion in the retina space.
6. Explain how to manage uveitis patients needing vitreoretinal surgery and the application of surgical techniques to successfully address complex vitreoretinal pathology in patients with uveitis.

AMA PRA Category 1 Credits™ (1.50 hours), CME Non-Physician (Attendance) (1.50 hours)

In support of improving patient care, this activity has been planned and implemented by Beaumont Health, Medical Conference Planners, Intl. and Vit-Buckle Society.  Beaumont Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine CME: Beaumont Health designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support: This module is supported by educational grants from Alcon Vision, LLC, Bausch + Lomb and Regeneron Pharmaceuticals, Inc.

Unapproved Use: It is the policy of Beaumont Health to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this accredited CE activity may reference off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

References:

www.vitbucklesociety.org/vit-buckle-academy

www.retinapodcast.com

Mitigation of Relevant Financial Relationships: In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Beaumont Health implemented mechanisms to identify and mitigate relevant financial relationships with ineligible companies for all individuals in a position to control content of this activity.

Disclosures: Please click the faculty name to review the individual's financial relationships with ineligible companies.